| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/18/2002 | WO2001083786B1 Stable zymomonas mobilis xylose and arabinose fermenting strains |
| 07/18/2002 | WO2001083749A3 Gene and sequence variation associated with sensing carbohydrate compounds and other sweeteners |
| 07/18/2002 | WO2001083525A3 Modified peptides, comprising an fc domain, as therapeutic agents |
| 07/18/2002 | WO2001083503A3 MODULATION OF OLIGONUCLEOTIDE CpG-MEDIATED IMMUNE STIMULATION BY POSITIONAL MODIFICATION OF NUCLEOSIDES |
| 07/18/2002 | WO2001081590A3 Protein phosphatases |
| 07/18/2002 | WO2001081586A3 21657, a human short-chain dehydrogenase and uses thereof |
| 07/18/2002 | WO2001081556A3 Enzyme variants having one or more d-amino acid substitutions |
| 07/18/2002 | WO2001081408A3 G-protein coupled receptor (gpcr) agonists and antagonists and methods of activating and inhibiting gpcr using the same |
| 07/18/2002 | WO2001081377A3 Integrin/adhesion antagonists |
| 07/18/2002 | WO2001081307A3 Triaryl cation antibiotics from environmental dna |
| 07/18/2002 | WO2001079468A3 Drug metabolizing enzymes |
| 07/18/2002 | WO2001079282A3 Molecules associated with human reproduction |
| 07/18/2002 | WO2001079273A3 Viruses comprising mutated ion channel protein |
| 07/18/2002 | WO2001078789A3 Poliovirus replicons encoding therapeutic agents and uses thereof |
| 07/18/2002 | WO2001073117A9 Use of particles which have signal-emitting characteristics and at least one group with an affinity for marked nucleic acids |
| 07/18/2002 | WO2001072822A3 Genes involved in intestinal inflammatory diseases and use thereof |
| 07/18/2002 | WO2001072783A3 Production of secreted proteins by recombinant eukaryotic cells |
| 07/18/2002 | WO2001071041A3 Microarray-based analysis of polynucleotide sequence variations |
| 07/18/2002 | WO2001070946A3 Methods for in vivo diversification of single genes |
| 07/18/2002 | WO2001068839A9 Regulation of human lipoxin a4 receptor-like protein |
| 07/18/2002 | WO2001068705A3 Il-17 receptor like molecules and uses thereof |
| 07/18/2002 | WO2001066747A3 Proteins named fctrx and nucleic acids encoding same |
| 07/18/2002 | WO2001062920A3 Compositions and methods for diagnosis and therapy of malignant mesothelioma |
| 07/18/2002 | WO2001061019A9 A dominant selectable marker for gene transformation and disruption in yeasts |
| 07/18/2002 | WO2001058461A9 Mycobacterium ag85 complex-specific t cell peptides and use in diagnostic and therapeutic applications thereof |
| 07/18/2002 | WO2001057269A3 Nucleic acid detection methods using universal priming |
| 07/18/2002 | WO2001055366A9 T cell receptor libraries |
| 07/18/2002 | WO2001055309A3 Nucleic acids, proteins, and antibodies |
| 07/18/2002 | WO2001055304A3 Nucleic acids, proteins, and antibodies |
| 07/18/2002 | WO2001051520A9 Nogo receptor-mediated blockade of axonal growth |
| 07/18/2002 | WO2001049856A3 Drosophila enzymes, encoding nucleic acids and methods of use |
| 07/18/2002 | WO2001048242A3 Methods for amplifying and detecting multiple polynucleotides on a solid phase support |
| 07/18/2002 | WO2001044514A3 Methods and compositions for identifying morphogenic protein analogs using morphogenic protein responsive inhibitory elements |
| 07/18/2002 | WO2001009326A9 Constitutively active stat proteins and their uses for identifying modulators of activity including dysproliferative cellular changes |
| 07/18/2002 | WO2001005834A9 Human tumor necrosis factor receptors tr13 and tr14 |
| 07/18/2002 | WO2000078972A9 Regulation with binding cassette transporter protein abc1 |
| 07/18/2002 | WO2000076310A9 Transgenic animals for producing specific isotypes of human antibodies via non-cognate switch regions |
| 07/18/2002 | WO2000074741A3 Biological joint construct |
| 07/18/2002 | US20020095694 Nucleotide sequences coding polypeptide for use in generating disease resistant plants |
| 07/18/2002 | US20020095693 Animal model for use in the treatment of eating disorders |
| 07/18/2002 | US20020095692 Viral polypeptide for use in the treatment and prevention of viral diseases |
| 07/18/2002 | US20020095691 Method of assaying modulators of hypertension |
| 07/18/2002 | US20020095032 Nucleotide sequences coding protein; for use in generating plants which haave amplified salt tolerances |
| 07/18/2002 | US20020095031 Novel human polynucleotides and polypeptides encoded thereby |
| 07/18/2002 | US20020095030 Nucleotide sequences coding preferfential polypeptides for use in the treatment of apotosis defects |
| 07/18/2002 | US20020095027 Polypeptide for use in the diagnosis and treatment of viral diseases in animals |
| 07/18/2002 | US20020095024 B7-related nucleic acids and polypeptides useful for immunomodulation |
| 07/18/2002 | US20020095023 Membrane protein for use in the treatment of allergies, parkinson's, alzheimer's and apoptitic defects |
| 07/18/2002 | US20020094968 Protein having isoleucine-serine-tryptophan-isoleucine (ISWI) sequence, an ATPase, able to remodel chromatin; facilitating cloning by contacting a somatic nucleus; dedifferentiating; immortalization; gene therapy; membrane transport |
| 07/18/2002 | US20020094967 Polynucleotide |
| 07/18/2002 | US20020094965 Purified and isolated polynucleotide molecules that encode the Chlamydia polypeptides designated glutamate binding protein which can be used in methods to prevent, treat, and diagnose Chlamydia pneumoniae; vaccines |
| 07/18/2002 | US20020094955 Plasminogen-like polynucleotides, polypeptides, and antibodies |
| 07/18/2002 | US20020094954 Nucleic acids comprising the neuregulin-1-associated gene 1 (NRG1AG1) |
| 07/18/2002 | US20020094584 Microfluidic apparatus for use in determining sequence of biopolymers |
| 07/18/2002 | US20020094575 Compositions and methods for stable transformation using Mu bacteriophage cleaved donor complex |
| 07/18/2002 | US20020094574 Recombinational cloning using nucleic acids having recombination sites |
| 07/18/2002 | US20020094565 Isolation of preferential nucleotide sequences from solution; obtain solution, insert pipette, suck out fluid, wash solution pipette, recover nucleotide sequences |
| 07/18/2002 | US20020094560 Peptide; for use in human therapeutics and diagnostics; for use in treatment of inflammation, cancer, arteriosclerosis, and psoriasis |
| 07/18/2002 | US20020094559 Nucleotide sequences coding enzymatic polypeptide for use in the treatment of cardiovascular disorders |
| 07/18/2002 | US20020094557 Enzymatic polypeptide for use in the generation of terpenes |
| 07/18/2002 | US20020094556 Enzymatic polypeptide for use in generation of preferential terpenes |
| 07/18/2002 | US20020094555 Composition for use in the treatment of cancer, inflammation and cell proliferation defects |
| 07/18/2002 | US20020094553 Glycosyl hydrolase genes and their use for producing enzymes for the biodegradation of carrageenans |
| 07/18/2002 | US20020094551 T2R taste receptors and genes ecncoding same |
| 07/18/2002 | US20020094539 Methods and reagents for analysis of RNA structure and function |
| 07/18/2002 | US20020094536 Methods for making polynucleotide libraries, polynucleotide arrays, and cell libraries for high-throughput genomics analysis |
| 07/18/2002 | US20020094533 Apparatus for assay, synthesis and storage, and methods of manufacture, use, and manipulation thereof |
| 07/18/2002 | US20020094530 Method to identify antibody targets |
| 07/18/2002 | US20020094529 Detecting preferential gene expression; obtain sample with nucletide sequences, incubate with modulator, monitor cell for preferential phenotype |
| 07/18/2002 | US20020094527 Probes and methods for detection of nucleic acids |
| 07/18/2002 | US20020094519 Detection of protein interactions |
| 07/18/2002 | US20020094518 Determining signal transduction pathways |
| 07/18/2002 | US20020094517 Double and triple readout assay systems |
| 07/18/2002 | US20020094516 Detecting preferential enzymatic polypeptide in cells; obtain cells, transform, culture cells, recover cells expressing preferential polypeptide, propagate cells |
| 07/18/2002 | US20020094340 Chlamydia antigens and corresponding dna thereof |
| 07/18/2002 | US20020094329 B.subtilis, wherein one or more genes involved in the biosynthesis of isovaleric acids have been modified such that the strain cannot produce substantial amounts of isovaleric acids; improved food flavors |
| 07/18/2002 | US20020094326 Treating tissue with phosphodiesterase inhibitor compound and administering exogenous nucleic acid |
| 07/18/2002 | US20020094324 Gene therapy for restenosis using an adenoviral vector |
| 07/18/2002 | DE10136702A1 System zur zell- und entwicklungsspezifischen Selektion differenzierender embryonaler Stammzellen, adulter Stammzellen und embryonaler Keimbahnzellen System for cell and developmental selection differentiating embryonic stem cells, adult stem cells and embryonic germ cells |
| 07/18/2002 | DE10123857A1 Verfahren zum Herstellen von heterologen Proteinen in einem homothallischen Pilz der Familie Sordariaceae A method for producing heterologous proteins in a homothallic fungus of the family Sordariaceae |
| 07/18/2002 | DE10101276A1 Verfahren und Vektoren zur Transformation von Plastiden Methods and vectors for transformation of plastids |
| 07/18/2002 | DE10101266A1 System for overexpressing cold-adapted enzymes, useful for food processing, includes expression control sequence comprising promoter and ribosome-binding site |
| 07/18/2002 | DE10100588A1 Inhibiting expression of target genes, useful e.g. for treating tumors, by introducing into cells two double-stranded RNAs that are complementary to the target |
| 07/18/2002 | DE10100280A1 DNA-Sequenzen, codierend für ein Apoptose-Signaltransduktionsprotein DNA sequences encoding an apoptosis-Signaltransduktionsprotein |
| 07/18/2002 | DE10065475A1 Use of intermediate-conductance potassium channel proteins for the diagnosis, prevention and treatment of disorders associated with disturbed keratinocyte activity, especially psoriasis |
| 07/18/2002 | DE10064983A1 New subtilisin protease from Bacillus alcalophilus, useful e.g. in washing and cleaning compositions, comprises at positions 230, 256 and 259 amino acids Val, Gly and Asn |
| 07/18/2002 | DE10060526A1 New DNA-methyltransferase M.EacI, useful for protecting double stranded DNA against cleavage by restriction enzymes, derived from Eubacterium acidaminophilum |
| 07/18/2002 | DE10060525A1 New restriction endonuclease EacI, useful for specific cleavage of double stranded DNA e.g. for analysis, derived from Eubacterium acidaminophilum |
| 07/18/2002 | DE10059631A1 T-Zellepitope des Papillomavirus L1-und E7-Proteins und ihre Verwendung in Diagnostik und Therapie T cell epitopes of the papillomavirus L1 and E7 protein and their use in diagnostics and therapy |
| 07/18/2002 | CA2697520A1 Use of lyophilised reduced diaminophenothiazines in the treatment of tau mediated neurological disorders |
| 07/18/2002 | CA2443800A1 Rice sucrose transporter gene promoter |
| 07/18/2002 | CA2436876A1 Transcriptional mediators of blood vessel development and endothelial differentiation |
| 07/18/2002 | CA2435874A1 Systems for expression of heterologous proteins in m. capsulatus |
| 07/18/2002 | CA2434926A1 Chemical inhibitors of mismatch repair |
| 07/18/2002 | CA2434672A1 Sfrp and peptide motifs that interact with sfrp and methods of their use |
| 07/18/2002 | CA2434567A1 Pharmaceutical compositions comprising modified cns-derived peptides for promoting nerve regeneration and prevention of nerve degeneration |
| 07/18/2002 | CA2434543A1 Inhibition of pathological angiogenesis in vivo |
| 07/18/2002 | CA2434402A1 Modular transfection systems |
| 07/18/2002 | CA2434394A1 Activation of nuclear transfer embryos |
| 07/18/2002 | CA2434269A1 Histone deacetylase inhibitors in diagnosis and treatment of thyroid neoplasms |